Hims & Hers is shutting down the dermatology business it acquired four years ago, Business Insider has learned. On Friday, the telehealth company discontinued Apostrophe, the direct-to-consumer ...

Apostrophe, a Bay Area telehealth company focused on skin care, shut down after almost four years under the Hims & Hers ...

Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...

Hims and Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...

Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% ...

Hims Topical Finasteride & Minoxidil Spray is created by a process called compounding. Compounded medications are customized or altered to meet a specific need (in this case, mixing two active ...

Hims & Hers Health (NYSE ... a glimpse into whether demand remains strong even after switching patients onto other weight loss treatments, before deciding to invest in it. If there isn't a ...

Hims & Hers had been relying on ... glimpse into whether demand remains strong even after switching patients onto other weight loss treatments, before deciding to invest in it.

Shares of Hims & Hers Health (HIMS) tumbled 15% yesterday after Novo Nordisk (NVO) announced it was cutting the price of its GLP-1 weight-loss drug ... remaining supply before being shut down.